|
Match
|
Document |
Document Title |
|
|
US20090136443 |
Drug Carrier
The present invention has an object of providing a drug carrier capable of controlling in vivo pharmacokinetics. The present invention is directed to a drug carrier comprising a molecular assembly...
|
|
|
US20090011004 |
IMPROVED CARRIERS FOR DELIVERY OF NUCLEIC ACID AGENTS TO CELLS AND TISSUES
This invention relates to drug delivery and specifically to the preparation and use of functionalized carriers such as nanopolymers and nanovesicles for improved delivery of nucleic acid agents...
|
|
|
US20080152616 |
Amphiphilic block copolymer and polymeric compostition comprising the same for drug delivery
The present invention relates to an amphiphilic block copolymer of a hydrophilic block and a hydrophobic block with a terminal hydroxyl group wherein the terminal hydroxyl group of the hydrophobic...
|
|
|
US20080124299 |
METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29
IL-28A, IL-28B, IL-29, and certain mutants thereof have been shown to have antiviral activity on a spectrum of viral species. Of particular interest is the antiviral activity demonstrated on...
|
|
|
US20080118460 |
Conjugates of polymer and pharmacologically active agents and a novel polymer blend
The instant invention provides a novel conjugate of a synthetic, biodegradable, exceedingly hydrophilic and non-proteinaceous polymer, whereby each of the above attributes is defined in the...
|
|
|
US20080112918 |
Method for treating gout and binding uric acid
A method for treating gout and/or reducing serum uric acid levels in a patient is disclosed that includes administering to the patient a therapeutically effective amount of an amine polymer, for...
|
|
|
US20080112917 |
Sphingolipids' Polyalkylamines Conjugates
The present invention concerns novel sphingolipid-polyalkylamines conjugates, a process for their preparation and pharmaceutical compositions comprising the same. In particular, the present...
|
|
|
US20080112891 |
Encapsulated (Chelate or Ligand) Dendritic Polymers
An encapsulated chelate dendritic polymer and an encapsulated ligand dendritic polymer are disclosed which have unique properties. These encapsulated chelate dendritic polymers may have associated...
|
|
|
US20080107618 |
USE OF FULLERENES FOR THE TREATMENT OF MAST CELL AND BASOPHIL-MEDIATED DISEASE
Mast cell (MC) and peripheral blood basophil (PBB)-associated diseases are treated or prevented, or their symptoms are alleviated by the administration of water soluble fullerenes (buckeyballs) to...
|
|
|
US20080057024 |
STIMULI RESPONSIVE POLYESTER AMIDE PARTICLES
A composition including a solution suitable for introduction into a blood vessel comprising particles including a treatment agent and a tunable stimuli-responsive polymer. A method including...
|
|
|
US20080025943 |
Modified two-component gelation systems, methods of use and methods of manufacture
Compositions, methods of manufacture and methods of treatment for post-myocardial infarction are herein disclosed. In some embodiments, the composition includes at least two components. In one...
|
|
|
US20080003253 |
Block copolymers including a methoxyethyl methacrylate midblock
A block copolymer comprising a methoxyethyl methacrylate (MOEMA) midblock is provided for forming a coating a medical device for controlled release of a bioactive agent.
|